Provided by Tiger Trade Technology Pte. Ltd.

Agree

72.50
+0.25000.35%
Post-market: 72.890.3900+0.54%19:30 EDT
Volume:1.44M
Turnover:104.07M
Market Cap:9.02B
PE:39.15
High:72.95
Open:72.42
Low:72.21
Close:72.25
52wk High:82.08
52wk Low:69.56
Shares:124.38M
Float Shares:122.18M
Volume Ratio:1.42
T/O Rate:1.18%
Dividend:3.14
Dividend Rate:4.33%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.42
PE(LYR):40.96

Loading ...

Pyxis Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Yesterday

Press Release: Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation

Dow Jones
·
Yesterday

Agree Realty Director John Rakolta Jr Acquires ADC Common Shares Worth $1.47 Million

Reuters
·
Aug 31

Hormuz Traffic Teeters as Iran-Oman Agree to Revenue-Sharing Framework

TIPRANKS
·
Aug 27

CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines

MT Newswires Live
·
Aug 26

CSPC’s EGFR-Targeting ADC Hits Phase III Milestone in Resistant Lung Cancer

TIPRANKS
·
Aug 26

Market Chatter: Hyundai Motor, Labor Union Agree on Tentative Wage Deal

MT Newswires Live
·
Aug 25

Greenvale, Patronus Agree to Amend Timetable for Northern Territory Project Uranium Rights Acquisition; Greenvale Shares Jump 8%

MT Newswires Live
·
Aug 24

Agree Realty (ADC) Could Be 13% Undervalued On Its Monthly Dividend Update

Simply Wall St.
·
Aug 23

Hidropar Shareholders Agree $6.5 Million Control-Change Deal With New Investor

TIPRANKS
·
Aug 21

China, Switzerland Agree On Trade Deal Scrapping Most Tariffs

MT Newswires Live
·
Aug 21

CSTONE PHARMA-B Gets NMPA Green Light for CS5007 Investigational New Drug Application

Stock News
·
Aug 21

CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007

TIPRANKS
·
Aug 21

Kronox Promoters Agree to Sell Majority Stake to Indo Borax

TIPRANKS
·
Aug 20

Lepu Biopharma Delivers Revenue Growth as ADC Pipeline Advances

TIPRANKS
·
Aug 19

Agree Realty Declares Monthly Distribution of R$ 0.12 Per Unit, Payable Aug. 20

Reuters
·
Aug 18

Akari Therapeutics Reaffirmed Buy as Analyst Keeps $27 Price Target on Advancing Trop2 ADC and Strengthened PH1 Platform

TIPRANKS
·
Aug 17

Breakthrough: AstraZeneca and Daiichi Sankyo's ADC Shows Strong Efficacy in First-Line Lung Cancer Therapy

Stock News
·
Aug 17

ADC Therapeutics price target lowered to $5 from $10 at Guggenheim

TIPRANKS
·
Aug 17

ADC Therapeutics reports Q2 adjusted EPS (11c) vs. (25c) last year

TIPRANKS
·
Aug 17